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Abstract 1 
Cyprodinil is a new-generation anilinopyrimidine fungicide widely used in crop protection 2 
and frequently found in fruits. In this study, novel derivatives of cyprodinil with linker site 3 
heterologies were synthesized and employed in order to produce antibodies with enhanced affinity. 4 
Moreover, moiety-heterologous haptens were designed and prepared for assay sensitivity 5 
improvement. Two competitive enzyme-linked immunosorbent assays for the analysis of this active 6 
substance were developed using direct and indirect formats, achieving IC50 values around 0.15 7 
µg/L. Analytical figures of merit and usability of the optimized assays were evaluated with wine and 8 
cider as model food processed matrices. The obtained recoveries were from 90% to 120%, and the 9 
limit of quantification was in the 1 to 5 µg/L range. Finally, a monitoring study (n=150) was 10 
performed to estimate the occurrence and the concentration of cyprodinil in commercial wine and 11 
cider products from different origins. We found that 28% of the analysed wine samples contained 12 
cyprodinil residues at levels higher than 5 µg/L. 13 
 14 
Keywords 15 
ELISA, Hapten design, Fungicide, Food analysis, Wine, Cider. 16 
 17 
Chemical compounds studied in this article 18 
Cyprodinil (PubChem CID: 86367); Pyrimethanil (PubChem CID: 91650); Mepanipyrim (PubChem 19 
CID: 86296); N,N’-disuccinimidyl carbonate (PubChem CID: 676246)  20 
 21 
Abbreviations used 22 
BSA: bovine serum albumin; CR: cross-reactivity; CB: coating buffer; cELISA: competitive enzyme-23 
linked immunosorbent assay; DMF: N,N-dimethylformamide; GAR: goat anti-rabbit 24 
immunoglobulin; HRP: horseradish peroxidase; LOQ: limit of quantification; MR: molar ratio; OVA: 25 
ovalbumin; PB: phosphate buffer; PBS: phosphate buffered saline; PBST: PBS containing Tween 26 
20. 27 
28 
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1. Introduction 29 
Anilinopyrimidines (cyprodinil, pyrimethanil, and mepanipyrim, Table 1) are new-generation 30 
and highly efficient compounds active against a broad-spectrum of fungal pests. They show a 31 
particular mode of action consisting in the inhibition of methionine biosynthesis, so they are 32 
frequently combined with other fungicides possessing a different target site. Cyprodinil was the first 33 
anilinopyrimidine active ingredient to be introduced in all European countries (Pesticide Properties 34 
DataBase). Nowadays, cyprodinil-based formulations are widely employed for plant and crop 35 
protection. According to different monitoring programs, cyprodinil is one of the most commonly 36 
found residues (EFSA, 2013; USDA, 2012). In order to regulate the presence of toxic compounds 37 
in food commodities, the European Food Safety Authority (EFSA) has established maximum 38 
residue levels (MRLs) as the upper legal concentration of a chemical to guarantee the lowest 39 
possible consumer exposure whilst reaching adequate phytosanitary efficiency (EU Pesticide 40 
Database). Those MRLs generally refer to raw or baby food products, but the legal pesticide 41 
contents for most processed foodstuff are not regulated yet in the EU. Nevertheless, different 42 
studies have confirmed the persistence of pesticides after industrial processing, for example during 43 
fermentation of grape must, with common concentrations in wine at micrograms per litre level 44 
(Cabras & Angioni, 2000; Cabras, et al., 1997; Edder, et al., 2009; González-Rodríguez, Cancho-45 
Grande, & Simal-Gándara, 2011). In addition, the presence of more than one residue has been 46 
repeatedly found in such high added value goods (Carpinteiro, Ramil, Rodriguez, & Cela, 2010; 47 
Pesticide Action Network, 2008; Trosken, Bittner, & Volkel, 2005). 48 
Several methods have been described for the detection of cyprodinil traces in wines, based 49 
on gas or liquid chromatography with mass spectrometry detection. A previous extraction step is 50 
usually employed to avoid matrix effects, such as solid-phase microextraction with divinylbenzene–51 
carboxen–polydimethylsiloxane fibers (Rial-Otero, Yagüe-Ruiz, Cancho-Grande, & Simal-Gándara, 52 
2002), liquid–liquid extraction (Vaquero-Fernández, et al., 2008), solid-phase extraction with Oasis 53 
HLB cartridges (Fontana, Rodríguez, Ramil, Altamirano, & Cela, 2011), dispersive liquid–liquid 54 
microextraction (Rodríguez-Cabo, Rodríguez, Ramil, & Cela, 2011), or the QuEChERS (quick, 55 
easy, cheap, effective, rugged, and safe) procedure (Moeder, Bauer, Popp, van Pinxteren, & 56 
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Reemtsma, 2012; Walorczyk, Drozdzynski, & Gnusowski, 2011). Also, immunoassays have been 57 
developed and validated in wines for the analysis of pesticides like benalaxyl (Rosso, Giraudi, 58 
Gamberini, Baggiani, & Vanni, 2000), tebufenozide (Irwin, Tolhurst, Jackson, & Gale, 2003), 59 
fenhexamid (Mercader & Abad-Fuentes, 2009), or bromopropylate (Ramon-Azcón, Sánchez-60 
Baeza, Sanvicens, & Marco, 2009), showing excellent performance. 61 
Immunoassays can be nowadays considered a mature technology for the analysis of 62 
chemical residues and contaminants in food and the environment, being the competitive enzyme-63 
linked immunosorbent assay (cELISA) one of the most employed setups. This immunochemical 64 
method is rapid, simple, sensitive, and specific; nevertheless, when cELISAs are compared with 65 
standard chromatographic methods, the main advantages of the bioanalytical method are the high 66 
sample throughput and the minimum sample treatment. Immunoassays are strongly recommended 67 
for the analysis of a high number of samples with reduced costs (Meulenberg, Mulder, & Stoks, 68 
1995). In a previous study, polyclonal antibodies against cyprodinil were generated for the first time 69 
by our group (Esteve-Turrillas, Agulló, Abad-Fuentes, Abad-Somovilla, & Mercader, 2012). Now, 70 
with the aim of analysing traces of cyprodinil in fermented drinks by immunoassay, we have 71 
designed two novel regioisomeric immunizing haptens with linker site heterologies in order to 72 
produce higher-affinity antibodies. Moreover, assay conjugates were prepared with new haptens 73 
bearing moiety heterologies for assay sensitivity enhancement. With those novel immunoreagents, 74 
a direct and an indirect cELISA have been optimized for the analysis of cyprodinil in white, red, and 75 
sparkling wines and in cider samples. For further validation, the developed immunoassays were 76 
applied to the analysis of cyprodinil in a variety of commercial wines from different origins. 77 
 78 
2. Materials and methods 79 
2.1. Reagents and instrumentation 80 
Cyprodinil (4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine, CAS Registry 121552-61-2, 81 
Mw 225.29 g/mol) and other pesticide standards were purchased from Fluka/Riedel-de-Haën 82 
(Seelze, Germany) or Dr. Ehrenstorfer (Augsburg, Germany). Horseradish peroxidase (HRP), 83 
ovalbumin (OVA), and o-phenylenediamine were purchased from Sigma/Aldrich (Madrid, Spain). 84 
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Bovine serum albumin (BSA) was from Roche Applied Science (Mannheim, Germany). Sephadex 85 
G-25 HiTrap Desalting and HiTrap Protein G HP columns from GE Healthcare (Uppsala, Sweden) 86 
were used for conjugate purification. Polyclonal goat anti-rabbit immunoglobulin peroxidase 87 
conjugate (GARHRP) was from Biorad (Hercules, CA, USA). Foetal bovine serum and Freund’s 88 
adjuvants were from Sigma/Aldrich (Madrid, Spain). Costar flat-bottom high-binding polystyrene 89 
ELISA plates were from Corning (Corning, NY, USA). Ultravioletvisible spectra and ELISA 90 
absorbances were read (in dual wavelength mode, 492650 nm) with a PowerWave HT 91 
microplate reader from BioTek Instruments (Winooski, VT, USA). ELISA plates were washed with 92 
an ELx405 microplate washer also from BioTek Instruments. Most stable conformers were 93 
calculated using CONFLEX with MM3 molecular mechanics to systematically search for low-94 
energy conformers, followed by geometry optimization in MOG using AM1 parameters and 95 
including aqueous solvation effects simulated by COSMO (CAChe WorkSystem Pro, version 96 
7.5.0.85). 97 
Different buffers were employed in this study. The composition, concentration, and pH of 98 
the employed buffers were: i) Phosphate buffer (PB), 100 mM sodium phosphate buffer (pH 7.4); ii) 99 
Phosphate buffered saline (PBS), 10 mM sodium phosphate buffer (pH 7.4) with 140 mM NaCl; iii) 100 
PBST, PBS containing 0.05% (v/v) Tween 20; iv) Carbonate buffer (CB), 50 mM 101 
carbonatebicarbonate buffer (pH 9.6); v) Washing solution, 15 mM NaCl and 0.05% (v/v) Tween 102 
20; vi) Developing buffer, 25 mM citrate and 62 mM sodium phosphate buffer (pH 5.4); and vii) 103 
PBST-2x, 20 mM sodium phosphate buffer (pH 7.4) with 280 mM NaCl and 0.05% (v/v) Tween 20. 104 
2.2. Hapten synthesis and activation 105 
 Preparation details and characterization data of new immunizing haptens (CDb and CDm) 106 
and heterologous assay haptens (Clp and Clm) are described in the Supplementary Material file. 107 
Carboxyl functionalized haptens were activated using N,N’-disuccinimidyl carbonate, and the 108 
corresponding NHS ester was purified by flash chromatography following a previously published 109 
procedure (Esteve-Turrillas, et al., 2010). Briefly, the hapten (0.1 mmol) and N,N’-disuccinimidyl 110 
carbonate (33.3 mg, 0.13 mmol, 1.3 equiv.) were dissolved in anhydrous CH3CN (0.7 mL) under 111 
nitrogen atmosphere at 0 ºC. Dry Et3N (38.4 mg, 53 µL, 0.38 mmol, 3.8 equiv.) was added and the 112 
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reaction mixture was stirred at 0 ºC for 1 h and then at room temperature until TLC (CHCl3/MeOH 113 
9:1 as eluent) showed completion of the reaction (ca. 12 h). The solution was diluted with 114 
chloroform, washed with an aqueous saturated solution of NaHCO3 and brine, and then dried over 115 
anhydrous Na2SO4. The residue that was left after evaporation of the solvent was purified by 116 
column chromatography, using chloroform as eluent, to give the corresponding active 117 
N-hydroxysuccinimidyl ester in high yields (8090%). 118 
2.3. Protein conjugate production 119 
Conjugates were prepared by coupling the purified NHS-activated ester of the synthetic 120 
haptens with three different carrier proteins (BSA, HRP, and OVA). Hapten-to-protein molar ratios 121 
(MR) of the purified conjugates were calculated using the absorbance values of the conjugate at 122 
280 nm, by assuming that the molar absorptions of the hapten and the protein were the same for 123 
the free and for the conjugated forms.  124 
2.3.1. Immunizing conjugates 125 
A 50 mM solution (200 µL) of CDb-NHS or CDm-NHS ester in DMF was added drop wise 126 
over 1.8 mL of a 15 mg/mL BSA solution in CB. The conjugation reaction was carried out during 4 127 
h at room temperature with moderate stirring. Next, the conjugate was separated from uncoupled 128 
hapten by gel filtration on Sephadex G-25, using PB as eluent, diluted to 1 mg/mL with the same 129 
buffer, sterilized with 0.45 µm filters, and stored at −20 °C.  130 
2.3.2. Tracer conjugates 131 
A 10 mM solution (100 µL) of CDb-NHS, CDm-NHS, Clp-NHS, or Clm-NHS in DMF was 132 
added drop wise over 0.9 mL of a 2.2 mg/mL HRP solution in CB. Reagents were allowed to 133 
couple during 4 h at room temperature with gentle stirring. The prepared conjugates were 134 
separated from uncoupled hapten by gel chromatography as described before. Purified conjugates 135 
were diluted 1:1 (v/v) with PBS containing 1% (w/v) BSA and 0.01% (w/v) thimerosal and stored at 136 
−20 °C in amber vials. For daily use, a working ali quot was kept at 4 °C. 137 
2.3.3. Coating conjugates 138 
A 100 mM solution (100 µL) of CDb-NHS, CDm-NHS, Clp-NHS, or Clm-NHS in DMF was 139 
added drop wise over 1.9 mL of a 15 mg/mL OVA solution in CB. The reaction was carried out 140 
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during 4 h at room temperature with moderate stirring. Then, conjugates were purified by gel 141 
chromatography as described. Finally, conjugates were stored at −20 °C in amber vials at 1 mg/mL 142 
in PB containing 0.01% (w/v) thimerosal. 143 
2.4. Antibody generation 144 
Animal manipulation was performed in compliance with the laws and guidelines of the 145 
Spanish Ministry of Agriculture, Food, and Environment, and approved by the Ethics Committee of 146 
the Universitat de València. Two female New Zealand white rabbits weighing 12 kg were 147 
immunized by subcutaneous injection with 0.3 mg of BSACDb or BSACDm conjugates in 1 mL 148 
of a 1:1 mixture of PB and complete Freund’s adjuvant. Animals were boosted at 21-day intervals 149 
with the same immunogen using incomplete Freund’s adjuvant. Whole blood was collected from 150 
the ear vein of the rabbits and by intracardiac puncture 10 days after the fourth injection. Blood 151 
samples were allowed to coagulate overnight at 4 °C . Then, the serum was separated by 152 
centrifugation, and a fraction was diluted 1/5 with PBS containing 0.01% thimerosal (w/v) and kept 153 
at 4 °C for daily usage. The remainder of each anti serum was precipitated twice with 1 volume of 154 
saturated ammonium sulphate solution, and stored at 4 °C.  155 
2.5. Antibody-coated direct competitive ELISA  156 
 Ninety-six-well polystyrene ELISA plates were coated with 100 µL of antiserum solution in 157 
CB, and plates were incubated overnight at room temperature. Coated plates were washed four 158 
times with washing solution and received, afterwards, 50 µL per well of analyte in PBS plus 50 µL 159 
per well of HRP tracer solution in PBST. For sample analysis, 50 µL per well of wine or cider 160 
conveniently diluted with Milli-Q water was mixed with 50 µL per well of HRP tracer solution in 161 
PBST-2x. The immunological reaction took place during 1 h at room temperature, and plates were 162 
washed again as before. Finally, retained peroxidase activity was determined by addition of 100 µL 163 
per well of freshly prepared 2 mg/mL o-phenylenediamine and 0.012% (v/v) hydrogen peroxide in 164 
developing buffer. The enzymatic reaction was stopped after 10 min at room temperature by the 165 
addition of 100 µL per well of 1 M sulphuric acid, and then absorbances were immediately read at 166 
492 nm with a reference wavelength at 650 nm.  167 
 168 
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 169 
2.6. Conjugate-coated indirect competitive ELISA  170 
Microplates were coated with 100 µL per well of OVA conjugate solution in CB by overnight 171 
incubation at room temperature. Coated plates were washed four times with washing solution, and 172 
then received 50 µL per well of analyte in PBS plus 50 µL per well of antiserum dilution in PBST.  173 
In the case of samples, 50 µL per well of wine or cider conveniently diluted with Milli-Q water was 174 
mixed with 50 µL per well of antibody solution in PBST-2x. The immunological reaction took place 175 
during 1 h at room temperature, and plates were washed again as described above. Next, 100 µl 176 
per well of a 1/104 dilution of GARHRP conjugate in PBST containing 10% (v/v) foetal bovine 177 
serum was added, and plates were incubated 1 h at room temperature. Finally, the signal was 178 
produced as aforementioned. 179 
2.7. ELISA data treatment 180 
Eight-point standard curves, including a blank, were set by serial dilution from the most 181 
concentrated point. For screening purposes, curves beginning with a 2000 µg/L cyprodinil solution 182 
in PBS were arranged by 10-fold serial dilution with the same buffer, and for sample analysis, a 183 
standard curve was prepared by 6-fold serial dilution in Milli-Q water of a 50 µg/L cyprodinil 184 
solution also in Milli-Q water. Sigmoidal curves were mathematically fitted to a four-parameter 185 
logistic equation using the SigmaPlot software package from SPSS Inc. (Chicago, IL, USA). Assay 186 
sensitivity was estimated as the concentration of analyte at the inflection point of the sigmoidal 187 
curve, typically corresponding to a 50% inhibition (IC50) of the maximum absorbance reached at 188 
zero dose of analyte (Amax) if the background signal approaches to zero.  189 
 190 
3. Results and discussion 191 
3.1. Hapten synthesis, activation, and conjugation 192 
In a previous study, two cyprodinil derivatives (CDn and CDp) with different linker tethering 193 
sites were prepared (Esteve-Turrillas, et al., 2012). In this work, two novel regioisomeric 194 
immunizing haptens have been designed; one with the linker at the pyrimidine ring (CDb) in order 195 
to have a completely different orientation of the molecule, and one with the linker at the aniline ring 196 
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(CDm) of the cyprodinil molecule, in a contiguous position compared to hapten CDp (Table 1). A 197 
similar synthetic strategy was followed for the synthesis of the novel immunizing haptens, CDb and 198 
CDm, which involved a condensation reaction between an aryl guanidine and a 1,3-dicarbonyl 199 
compound as the key synthetic step to construct the suitably functionalized anilinopyrimidine 200 
framework. The synthesis of hapten CDb is schematized in Fig. 1. It comprised the prior 201 
preparation of the 1,3-dicarbonyl compound 6, which bears the C5 carboxylated alkyl chain that 202 
constituted the spacer arm. Its preparation was carried out through the acylation reaction of allyl β-203 
oxopropanoate 3, obtained via Claisen condensation of cyclopropyl methyl ketone (1) with diallyl 204 
carbonate (2), with methyl  6-chloro-6-oxohexanoate (4), followed by palladium-catalyzed 205 
decarboxylative deallylation reaction. The thus obtained β-dicarbonylic compound 6, which exists 206 
in solution as a mixture with the enol tautomer, was subsequently condensed with phenylguanidine 207 
nitrate (7) in basic media to form the complete skeleton of hapten CDb, the synthesis of which 208 
ended with the hydrolysis of the methyl ester moiety of 8 in basic aqueous medium. 209 
The regioisomeric hapten CDm was prepared as illustrated in Fig. 2, and involved the 210 
preparation of the pyrimidine ring via a condensation reaction in basic medium of 1-211 
cyclopropylbutane-1,3-dione (9) with the aryl guanidine 11, which incorporated the C6 hydrocarbon 212 
chain that constituted the linker at the adequate position of the phenyl ring. This aryl-guanidine was 213 
readily prepared as the nitrate salt by nitric acid catalyzed reaction of methyl 6-(3-214 
aminophenyl)hexanoate (10) with cyanamide in an ethanolic medium. Once completed the 215 
anilinopyrimidine framework, the synthesis of hapten CDm was accomplished by basic hydrolysis 216 
of the methyl ester moiety of 12. Synthesis of the moiety heterologous haptens, Clp and Clm, was 217 
based on a strategy similar to that used for the preparation of haptens CDb and CDm.  218 
All haptens were activated by the active ester method, and conjugation to proteins was 219 
efficiently carried out with the chromatographically purified N-succinimidyl ester of the 220 
corresponding hapten, prepared in high yield using N,N’-disuccinimidyl carbonate as the activating 221 
reagent. Since no secondary reactions occurred by the followed coupling procedure, the same 222 
strategy could be employed for immunizing and assay conjugates. The MR of both BSA conjugates 223 
was 11. Regarding assay conjugates, the MRs were 3, 4, 4, and 3 for HRPCDb, HRPCDm, 224 
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HRPClp, and HRPClm, respectively, and 6, 8, 11, and 8 for OVACDb, OVACDm, OVAClp, 225 
and OVAClm, respectively. 226 
3.2. Antibody affinity 227 
Four novel antibodies, named CDm#1, CDm#2, CDb#1, and CDb#2, were produced from 228 
immunogens containing regioisomeric haptens CDm and CDb, respectively. In addition, previously 229 
reported antisera – CDp#1, CDp#2, CDn#1, and CDn#2 – and assay conjugates (Esteve-Turrillas, 230 
et al., 2012) were included in this study for a broader checkerboard heterologous competitive 231 
analysis, using direct and indirect cELISA formats. All immunizing haptens held equivalent linker 232 
arms (Table 1). Besides, conjugates carrying moiety-heterologous haptens (Clm and Clp) were 233 
evaluated with all of the available antibodies in both assay formats. For direct assays, plates were 234 
coated with several dilutions of the antiserum (from 3x103 to 3x104), and next day a range of tracer 235 
conjugate concentrations (from 1 to 300 µg/L) was evaluated under competitive conditions. For 236 
indirect assays, plates were coated with a solution of the respective OVA conjugate at 10, 100, or 237 
1000 ng/mL, and the competitive step was carried out using a range of antiserum dilutions (from 238 
3x103 to 1x106). Thus, a set of inhibition curves was obtained for every immunoreagent 239 
combination in both cELISA formats. Table S1 lists a summary of the results of the checkerboard 240 
competitive study, showing the respective inhibition curve parameters for direct and indirect 241 
cELISAs achieved with all of the antibodies and the linker site-heterologous conjugates. The 242 
overall trend of these results indicated that sensitivity in the direct format was higher than with the 243 
indirect one, but a broader conjugate recognition pattern was seen with the latter. As formerly 244 
observed, the antibodies obtained from hapten CDn showed the lowest affinity, in line with the 245 
results described elsewhere with an equivalent derivative of mepanipyrim – another compound of 246 
the same family (Esteve-Turrillas, Mercader, Agulló, Abad-Somovilla, & Abad-Fuentes, 2013). By 247 
comparison of homologous assays, it was seen that the highest affinity to cyprodinil was achieved 248 
with antibodies that had been produced using the novel CDb immunizing hapten – IC50 values 249 
were 1.31 and 0.81 µg/L for antisera CDb#1 and CDb#2, respectively. Moreover, linker site-250 
heterologies afforded improved IC50 values, even with CDn-type antibodies. Overall, with several 251 
heterologous immunoreagent combinations, IC50 values below 1.0 µg/L were retrieved.  252 
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In addition, two moiety-heterologous haptens (Clp and Clm) were synthetized with the aim 253 
of further improving IC50 values (Ahn et al., 2012; Shen et al., 2012; Suárez-Pantaleón, Mercader, 254 
Agulló, Abad-Somovilla, & Abad-Fuentes, 2011). These haptens held the linker at different 255 
positions of the aniline ring and contained a distal heterologous chemical group – a chlorine atom – 256 
at the pyrimidine ring replacing the cyclopropyl moiety of the cyprodinil molecule (Table 1). All of 257 
the available antibodies were challenged with these heterologous conjugates by checkerboard 258 
cELISA in both formats (Table S2). Interestingly, it was observed that CDp-type and CDm-type 259 
antibodies perfectly recognized both heterologous conjugates – signals higher than 1.0 were 260 
obtained at usual immunoreagent concentrations. Thus, the chlorine atom seemed to mimic fairly 261 
well the cyclopropyl moiety. On the contrary, with CDb-type antibodies – which were produced with 262 
a hapten carrying the linker at the pyrimidine ring – high immunoreagent concentrations were 263 
required to observe binding in the indirect format, whereas low or no binding was seen in the direct 264 
format, probably due to the opposite location of the spacer arm in haptens Clp and Clm if 265 
compared to the homologous hapten CDb. As expected, no signal was obtained with CDn-type 266 
antibodies, with the only rare exception of antibody CDn#1 with conjugate OVAClm, even though 267 
high antibody and conjugate concentrations were also needed. In general terms, the sensitivity of 268 
most assays was improved using these new competitive haptens, with many antibody/conjugate 269 
pairs showing IC50 values in the submicrogram per litre level. The most sensitive assay (IC50 = 0.13 270 
µg/L) was obtained with antibody CDp#2 in the direct format using tracer HRPClm. Fig. 3 shows 271 
the standard inhibition curves of the selected cELISAs obtained using antibody CDp#2 in the direct 272 
and indirect assay formats in combination with the moiety-heterologous tracer HRPClm and the 273 
linker site-heterologous conjugate OVACDb, respectively. 274 
3.3. Antibody selectivity 275 
Antibody selectivity towards anilinopyrimidines was assessed by cross-reactivity (CR) 276 
studies as the percentage value of the quotient between the IC50 value for cyprodinil and the IC50 277 
value for pyrimethanil or mepanipyrim (see Table 1 for the structures of these two compounds). 278 
Calibration curves were prepared up to 10 µM for every compound in PBS and measured by direct 279 
and indirect homologous cELISA. Results for the eight antibodies in the direct format are depicted 280 
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in Fig. 4a as radar line plots. The corresponding plot for the indirect assay is shown in the 281 
Supplementary Material file (Fig. S1). It was observed that the selectivity pattern was similar by 282 
direct and indirect cELISA, indicating a minute influence of the assay format. Interestingly, CDn-283 
type antibodies showed CR values around 100% for all three anilinopyrimidine fungicides, 284 
suggesting that the central derivatization position of hapten CDn (Fig. 4b) determined the 285 
generation of antibodies with a variety of preferred orientations of the molecule. On the contrary, 286 
the selectivity of all of the other antisera was generally good – CR values were generally between 287 
1% and 10% – no matter of the ring where the spacer arm was located at; either the aniline ring 288 
(CDp and CDm) or the pyrimidine ring (CDb). Moreover, mepanipyrim – characterized by a 1-289 
propinyl group – was less recognized than pyrimethanil – with a methyl moiety – by most of the 290 
antibodies, particularly by CDm-type antisera. Surprisingly, the most selective antibody was CDb#1 291 
– CRs around 1% for both compounds –, whose immunizing hapten (CDb) held both the linker and 292 
the specific cyclopropyl group at the same ring (Table 1). These results show that for such small 293 
molecules, the moieties located at a proximal ring also played a determinant role for selectivity, 294 
and in the case of hapten CDb, the cyclopropyl moiety could be properly displayed as presumed 295 
from the most stable conformer of cyprodinil (Fig. 4b). 296 
Selectivity was also evaluated for the appointed cELISAs using antibody CDp#2 with a 297 
moiety-heterologous tracer (HRPClm) for the direct immunoassay and a linker site-heterologous 298 
conjugate (OVACDb) for the indirect assay. In both cases, a slight increase of CR was observed 299 
when compared to the homologous assays – CR values to pyrimethanil and mepanipyrim were 300 
between 9% and 18%. As discussed above, the distal position of those heterologies helped to 301 
improve immunoassay sensitivity to cyprodinil; conversely, regarding selectivity, both distal 302 
heterologies accentuated the binding to other anilinopyrimidines. Thus, when using distal 303 
heterologies, antibody molecules with specificity towards the common aniline ring seemed to 304 
prevail in the competitive reaction.  305 
  306 
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3.4. Assay robustness 307 
Sample constituents may affect the cELISA response, so several potential interferents were 308 
evaluated in order to establish the robustness of the proposed immunoassays for the analysis of 309 
cyprodinil traces. White, red, and sparkling wines and apple cider were chosen as target samples.  310 
3.4.1. Alcohol tolerance 311 
Solvent contents in the sample often change the analytical parameters of an immunoassay 312 
(He et al., 2014; Mercader & Abad-Fuentes, 2009). Fermented drinks like wine or cider may 313 
contain important concentrations of ethanol, so the influence of alcohol over the inhibition curve of 314 
the proposed cELISAs needs to be evaluated. Cyprodinil standards were prepared in water 315 
containing different concentrations of ethanol and analyzed by the selected direct and indirect 316 
assays. Methanol was also included in the study for comparison. Fig. 5 shows the effect of those 317 
solvents over the Amax and IC50 values of the cyprodinil inhibition curves. It was seen that both 318 
immunoassays tolerated reasonably well the presence of a 5% (v/v) solvent concentration. 319 
3.4.2. Matrix effects 320 
Water dilution is a simple and common strategy to avoid interferences of the sample matrix 321 
over immunoassay analytical performance. Thus, cyprodinil standard curves were prepared using 322 
several dilutions (1/5, 1/15, and 1/50) of every evaluated matrix in water and analysed using the 323 
proposed direct and indirect cELISAs. Fig. S2 shows the variation of the inhibition curves at every 324 
sample dilution for white, red, and sparkling wines and for cider. A 1/15 sample dilution was 325 
considered appropriate to avoid matrix interferences, with the exception of red wine, for which a 326 
1/50 dilution was proposed. 327 
3.4.3. Fungicide interferences 328 
Cyprodinil commercial products are usually coformulated with other fungicides, like 329 
fludioxonil or picoxystrobin. Moreover, other active principles may be present in the sample. Thus, 330 
CR studies were performed with those and other commonly used fungicides such as: azoxystrobin, 331 
pyraclostrobin, kresoxim-methyl, trifloxystrobin, fenhexamid, boscalid, imidacloprid, procimidone, 332 
cyazofamid, tolylfluanid, tebuconazole, fenamidone, vinclozolin, proquinazid, epoxiconazol, and 333 
propiconazol. From this study, it was seen that no antibody recognized any of the listed 334 
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compounds – CR values were lower than 0.1% –, so no interferences from these substances with 335 
the proposed cELISAs can be expected.  336 
3.5. Recovery studies 337 
Trueness of the selected assays was evaluated by spiking cyprodinil-free wine and cider 338 
samples with known amounts of this fungicide from 1 to 1000 µg/L. After adequate water dilution, 339 
fortified samples were analysed by the developed cELISAs. Recoveries (Table 2) ranged from 97% 340 
to 120% and from 90% to 116% for direct and indirect assays, respectively, and relative standard 341 
deviation remained mostly lower than 15%. From this study, the high sensitivity of the proposed 342 
cELISAs was evidenced. The limit of quantification (LOQ) of the method is defined as the lowest 343 
validated spiked level meeting the method performance acceptability criteria – mean recoveries in 344 
the range 70-120%, with RSD values ≤ 20% (DG SANCO, 2007) – was 1 µg/L for the direct assay, 345 
except for red wine, and 5 µg/L with the indirect cELISA, except for white wine. Thus, the optimized 346 
immunoassays are suitable for the determination of very small traces of cyprodinil in alcoholic 347 
fermented drinks. 348 
3.6. Sampling study 349 
The usefulness of the developed method to identify and quantify fungicide residues in wine 350 
was assessed using commercial samples acquired in local supermarkets. A total of 150 samples of 351 
commercial wine and cider samples encompassing 84 red, 57 white, and 6 sparkling wines and 3 352 
cider samples were screened for the analysis of cyprodinil residues. Samples from different origins 353 
(Spain, Germany, Italy, France, Portugal, USA, and South Africa) were included in the survey, and 354 
they were analysed by the indirect cELISA. We found that 28% of the wine samples contained 355 
residues of cyprodinil, considering the LOQ for this method was 5 µg/L. No residues were detected 356 
in cider samples. In detail, 44% of red wines contained detectable residues of cyprodinil, while 357 
lower percentages were obtained for white and sparkling wines (7 and 17%, respectively). 358 
Remarkably, the presence of cyprodinil in positive samples was confirmed by a reference 359 
procedure based in a QuEChERS extraction (Walorczyk, et al., 2011) and UPLC/MSMS 360 
determinations.  361 
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The maximum concentration found for every type of wine was 74, 11, and 18 µg/L for red, 362 
white, and sparkling wines, respectively. The obtained results are in accordance to literature data 363 
regarding other wine monitoring studies using chromatographic analytical methods. For example, 364 
the Pesticide Action Network encountered concentrations of cyprodinil in wine from 1 to 15 µg/L 365 
(Pesticide Action Network, 2008), Rial-Otero et al. found cyprodinil between 0.9 and 25 µg/L (Rial-366 
Otero, et al., 2002), cyprodinil contents observed by Čuš et al. were from 10 to 440 µg/L (Cus, 367 
Cesnik, Bolta, & Gregorcic, 2010), and Rodríguez-Cabo et al. (2011) and Fontana et al. (2011) 368 
reported cyprodinil levels up to 43 µg/L. 369 
 370 
4. Conclusions 371 
Traces of pesticides have been found in fermented alcoholic drinks such as wine. With the 372 
aim of developing rapid and sensitive analytical methods for cyprodinil residue control, two novel 373 
immunizing haptens were designed and high-affinity antibodies were produced. In addition, two 374 
moiety-heterologous compounds were synthesized for competitive assay sensitivity improvement. 375 
Enhanced assay sensitivity was achieved by employing linker site and moiety heterologies, with 376 
IC50 values of 0.13 and 0.17 µg/L for the direct and the indirect competitive format, respectively.  377 
We observed that, for very small molecules such as anilinopyrimidines, proximal moieties to the 378 
linker site of the immunizing hapten can actively participate in the antibody-antigen interaction, as 379 
demonstrated by cross-reactivity studies with the polyclonal antibodies described herein. The 380 
optimized assays were validated for the analysis of cyprodinil residues in fortified wine and cider 381 
samples, reaching LOQ values between 1 and 5 µg/L, recoveries from 90 to 120%, and RSD 382 
values lower than 17%. A monitoring study conducted with the developed indirect cELISA 383 
demonstrated the presence of cyprodinil residues in 28% of commercial wine samples, proving the 384 
high applicability of this analytical tool for pesticide surveillance studies in such high added value 385 
products. 386 
 387 
  388 
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Figure captions 496 
 497 
Fig. 1. Synthesis pathway to prepare hapten CDb. 498 
 499 
Fig. 2. Synthesis pathway to prepare hapten CDm. 500 
 501 
Fig. 3. Standard inhibition curves of the selected direct and indirect cELISAs using antibody 502 
CDp#2 with tracer HRPClm and conjugate OVACDb, respectively.  503 
 504 
Fig. 4. A) Radar line plots of cross-reactivity values (%) for pyrimethanil (grey) and mepanipyrim 505 
(ochre) by homologous direct cELISA obtained with each pair of antibodies generated from every 506 
immunizing hapten. B) Cyprodinil most stable conformer. Elements are presented as follows: 507 
carbon, grey; hydrogen, white; nitrogen, blue. Arrows point out the spacer site of the four synthetic 508 
immunizing haptens. 509 
 510 
Fig. 5. Variation of Amax and IC50 values of the cyprodinil standard inhibition curve of the selected 511 
cELISAs (direct: solid lines; indirect: dashed lines) at different ethanol (ochre lines) and methanol 512 
(grey lines) concentrations in the assay buffer. 513 
 514 
Table 1 
Structures of anilinopyrimidine fungicides and synthetic haptens. 
 
 R1 R2 R3 R4 R5 
Anilinopyrimidine      
Cyprodinil CHCH2CH2 CH3 H H H 
Pyrimethanil CH3 CH3 H H H 
Mepanipyrim CCCH3 CH3 H H H 
      Immunizing haptens      
CDp CHCH2CH2 CH3 H H (CH2)5COOH 
CDm CHCH2CH2 CH3 H (CH2)5COOH H 
CDn CHCH2CH2 CH3 (CH2)4COOH H H 
CDb CHCH2CH2 (CH2)4COOH H H H 
      Moiety-heterologous haptens      
Clp Cl CH3 H H (CH2)5COOH 
Clm Cl CH3 H (CH2)5COOH H 
 
  
 
 
 
 
 
 
Table 1
Table 2 
Recoveries from spiked alcoholic fermented drinks measured by the 
developed cELISAs. 
cELISA 
Spiked 
(µg/L) 
Recovery (% ± s, n=3)a 
White wine Red wine Sparkling wine Cider 
Direct 1 120 ± 9 -b  97  ± 11 113  ± 15 
 5 114  ± 15 115  ± 2 110  ± 4 104  ± 9 
 10 120  ± 10 110  ± 9 102 ± 3 102  ± 2 
 50  105  ± 9 109  ± 14 101  ± 5 111  ± 15 
 100  108  ± 12 106  ± 17 104  ± 3 99  ± 1 
 500  103  ± 4 102  ± 10 97  ± 4 97  ± 1 
 1000  99  ± 1 105  ± 9 105 ± 8 98  ± 6 
Indirect 1 116  ± 11 -b  -b  -b  
 5 116  ± 9 94  ± 14 108  ± 8 106  ± 11 
 10 109  ± 6 90  ± 2 109  ± 15 109  ± 10 
 50  106  ± 10 109  ± 12 98  ± 9 103  ± 4 
 100  111  ± 6 103  ± 12 95  ± 12 111  ± 3 
 500  105  ± 15 100  ± 10 100  ± 1 111  ± 12 
 1000  102  ± 2 100  ± 6 96  ± 7 110  ± 11 
a Samples spiked at 1-10 µg/L were diluted in water 1/50 for red wine and 1/15 for 
the other drinks, whereas for samples spiked at 50-1000 µg/L higher dilutions were 
employed . b Inconsistent results.  
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General Information 
Phenylguanidine nitrate salt (7) was prepared from reaction of aniline, cyanamide and nitric acid 
following a literature procedure.1 1-cyclopropylbutane-1,3-dione (9) was prepared from 
cyclopropyl methyl ketone, EtOAc and potassium tert-butoxide according to a procedure 
previously described.2 6-(3-Aminophenyl)hexanoate (10) was prepared by esterification of the 
corresponding acid3 with MeOH and catalytic SOCl2.
4 4-Chloro-6-methyl-2-(methylsulfonyl) 
pyrimidine (13) was prepared from commercially available 4-hydroxy-2-mercapto-6-
methylpyrimidine following a previously described three steps synthetic route.5 N-(4-
iodophenyl)formamide (14) and N-(4-iodophenyl)formamide (20) were obtained by N-formylation 
of the corresponding iodophenylaniline.6,7 Other reagents were acquired from commercial 
sources and used without purification. Reactions were monitored with the aid of thin layer 
chromatography using 0.25 mm precoated silica gel plates. Visualization was carried out with UV 
light and a 50% (v/v) aqueous ceric ammonium molybdate solution. Chromatography refers to 
flash column chromatography, and it was carried out with the indicated solvents on silica gel 60 
(particle size = 0.040−0.063 mm). All melting points were determined using a Kofler hot-stage 
apparatus and are uncorrected. NMR spectra were recorded on a Bruker AC-300 spectrometer 
(300.13 MHz for 1H and 75.47 MHz for 13C), and they were referenced to residual solvent protons 
in the 1H NMR spectra (7.26, 3.58/1.73 and 2.50 ppm for CDCl3, THF-d8 and DMSO-d6, 
respectively) and to solvent carbons in the 13C NMR spectra (77.0, 67.6 and 39.43 ppm for 
CDCl3, THF-d8 and DMSO-d6, respectively). Carbon substitution degrees were established by 
distortionless enhancement by polarization transfer (DEPT) pulse sequences. Infrared (IR) 
spectra were measured using a Nicolet Avatar 320 spectrometer. Mass spectra (MS) and high-
resolution mass spectra (HRMS) were run either by the electron impact (EI, 70 eV), obtained with 
                                                 
1
 N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase 
Kinase 3 with Good Cellular Efficacy. F. X. Tavares; J. A. Boucheron; S. H. Dickerson; R. J. Griffin; F. Preugschat; S. 
A.Thomson; T. Y.Wang; H. Q. Zhou. J. Med. Chem. 2004, 47, 4716-4730. 
2
 Process for the preparation of 1-cyclopropylalkane-1, 3-diones. J. Muhr, Patent Number US5545762. Date of Patent: 
Aug. 13, 1996. 
3
 Synthesis and Polyclonal Antibody-Based Immunoassay Development for the Analysis of Forchlorfenuron in Kiwifruit. 
C. Suarez-Pantaleon,; , J. V. Mercader; C. Agullo; A. Abad-Somovilla; A. Abad-Fuentes. J. Agric. Food Chem., 2010, 
58, 8502-8511. 
4
 Design, Synthesis, and Pharmacological Evaluation of Thapsigargin Analogues for Targeting Apoptosis to Prostatic 
Cancer Cells. C. M. Jakobsen; S. R. Denmeade; J. T. Isaacs; A. Gady; C. E. Olsen; S. B. Christensen. J. Med. Chem. 
2001, 44, 4696-4703. 
5 Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization 
inhibitors. D. D. Davey; M. Adler; D. Arnaiz; K. Eagen; S. Erickson; W. Guilford; M. Kenrick; M. M. Morrissey; M. 
Ohlmeyer; G. Pan; V. M. Paradkar; J. Parkinson; M. Polokoff; K. Saionz; C. Santos; B. Subramanyam; R. Vergona; R. 
G. Wei; M. Whitlow; B. Ye; Z. Zhao; J. J. Devlin; G. Phillips. J. Med. Chem. 2007, 50, 1146-1157. 
6 Synthesis of 3,1-benzothiazines by cyclization of 2-thioformylaminodiphenylacetylenes . M. A. Fernandes; D. H. Reid. 
Synlett, 2003, 2231-2233. 
7 Understanding the Anchoring Group Effect of Molecular Diodes on Rectification. Y. Lee; B. Carsten; L. Yu. Langmuir, 
2009, 25, 1495-1499. 
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a Micromass VG Autospec spectrometer, or the electrospray (ES) mode, which was obtained with 
a Q-TOF premier mass spectrometer with an electrospray source (Waters, Manchester, UK). 
Hapten Synthesis 
a) Synthesis of Hapten CDb 
 
Preparation of allyl 3-cyclopropyl-3-oxopropanoate (3). Diallyl carbonate (2, 1.0 g, 2.55 ml, 17.82 
mmol, 1.5 equiv.) and 1-cyclopropylethanone (1, 1.17 mL, 11.88 mmol, 1 equiv.) were 
successively added into a stirred suspension of HNa (60% dispersion in mineral oil, 1.19 g, 29.75 
mmol, 2.5 equiv.) in anhydrous benzene (5 mL) at rt under nitrogen and the mixture was refluxed 
for 5 h. The reaction mixture was cooled to 0 ºC, cautiously treated with 3 M HCl solution to acidic 
pH and extracted with CH2Cl2. The organic extracts were washed with brine, dried over 
anhydrous MgSO4 and concentrated to dryness. The residue was chromatographed, using 
hexane-Et2O 9:1 as eluent, to afford the β-ketoester 3 as an oil (1.36 g, 60%). 
1H NMR (CDCl3) δ 
(ppm) 5.88 (1H, ddt, J =17.2, 10.4, 5.7 Hz, H-2 allyl), 5.32 (1H, ddt, J = 17.2, 1.5, 1.5 Hz, H-3 
allyl), 5.23 (1H, ddt, J = 10.4, 1.5, 1.4 Hz, H’-3 allyl), 4.62 (2H, dt, J = 5.7, 1.4 Hz, H-1 allyl), 3.58 
(2H, s, H-2), 2.02 (1H, tt, J = 4.5, 4.4 Hz, CH-Cy), 1.09 and 0.95 (2H each, each m, CH2CH2-Cy); 
13C NMR (CDCl3) δ (ppm) 202.4 (C-1), 166.6 (C-3), 131.5 (C-2 allyl), 118.4 (C-3 allyl), 65.6 (C-1 
allyl), 49.6 (C-2), 20.6 (CH-Cy), 11.5 (CH2CH2-Cy); IR (NaCl) vmax/cm
-1 3088, 3012, 2943, 1736, 
1707, 1649, 1442, 1385, 1312, 1271, 1151, 1074, 992, 933, 735. HRMS m/z calcd. for C9H12O3 
168.07864, found 168.07884. 
 
Preparation of (E)-1-allyl 8-methyl 2-(cyclopropanecarbonyl)-3-hydroxyoct-2-enedioate (5). 
β-Ketoester 3 (288.3 mg, 1.5 mmol) was added to a stirred suspension of anhydrous MgCl2 
(142.8 mg, 1.5 mmol) in dry CH2Cl2 (2 mL) at rt under nitrogen. The reaction mixture was cooled 
to 0 ºC, dry pyridine (243 µL, 3 mmol) was added and the mixture was stirred at this temperature 
for 15 min. Then, methyl adipoyl chloride (4, 234 µL, 1.5 mmol) was added and the mixture was 
stirred at 0 ºC for 15 min. and then at rt for an additional 1 h. After the addition of cold 6 M HCl (3 
4 
 
mL) to the white slurry formed, the mixture was extracted with Et2O, the extracts were washed 
with brine and then dried over MgSO4. Evaporation of the solvent afforded the crude product that 
was purified by chromatography, using hexane-EtOAc 9:1 as eluent, to yield a yellowish oil 
corresponding to the expected β-diketone, which exists exclusively in the keto-enol tautomeric 
form 5 (457.5 mg, 98%). 1H NMR (CDCl3) δ (ppm) 5.98 (1H, ddt, J =17.2, 10.4, 5.9 Hz, H-2 allyl), 
5.32 (1H, ddt, J = 17.2, 1.5, 1.5 Hz, H-3 allyl), 5.23 (1H, ddt, J = 10.4, 1.3, 1.3 Hz, H’-3 allyl), 4.72 
(2H, dt, J = 5.9, 1.3 Hz, H-1 allyl), 2.60 (2H, m, H-7), 2.31 (3H, m, H-4 and CH-Cy), 1.66 (4H, m, 
H-5 and H-6), 1.22 and 0.99 (2H each, each m, CH2CH2-Cy). 
13C NMR (CDCl3) δ (ppm) 199.2 
(CO-Cy), 195.0 (C-3), 173.8 (CO2Me), 167.4 (C-1), 131.7 (C-2 allyl), 119.1 (C-3 allyl), 108.6 (C-
2), 65.7 (C-1 allyl), 51.5 (CO2Me), 36.6 (C-4), 33.7 (C-7), 25.4 (C-6), 24.5 (C-5), 16.6 (CH-Cy), 
12.1 (CH2CH2-Cy); IR (NaCl) vmax/cm
-1 3087, 3014, 2952, 2873, 1735, 1560, 1437, 1271, 1208, 
1101, 1062, 936, 737; MS (EI) m/z (%) 310 (M+, 0.7), 282 (0.6), 252 (1), 253 (0.5), 251 (0.4), 226 
(2.5), 220 (0.4), 195 (4), 143 (6.4), 126 (10), 111 (30), 69 (100); HRMS m/z calcd. for C16H22O6 
310.14164, found 310.14148. 
 
Preparation of (Z)-methyl 8-cyclopropyl-6-hydroxy-8-oxooct-6-enoate (6a) and methyl 
8-cyclopropyl-6,8-dioxooctanoate (6b). To a solution of allyl ester 5 (431 mg, 1.388 mmol) in THF 
(5.8 mL) at 0 °C were added Pd(PPh3)4 (105.6 mg, 0.091 mmol, 0.06 equiv.) and dropwise 
morpholine (254 µL, 2.916 mmol, 2 equiv.). The reaction mixture was allowed to warm to rt and 
stirred at this temperature for 40 min. The solvent was removed under reduced pressure and the 
remaining residue was purified by silica gel column chromatography, using hexane-Et2O 9:1 as 
eluent, to afford the keto-enol 6a (285.8 mg, 91%), which exists in CDCl3 solution as a mixture 
with the 6,8-diketo tautomer [ca. a 4:1 mixture of 6a and 6b]. 1H NMR (CDCl3) δ (ppm) 15.63 
(0.8H, s, OH, keto-enol form), 5.60 (0.8H, s, H-7 keto-enol form), 3.67 (3H, s, CO2Me 
keto-enol+diketo forms), 3.66 (0.4H, s, H-7 diketo form), 2.51 (0.4H, m, H-5 keto form), 2.34 (2H, 
t, J = 7.1 Hz, H-2 keto-enol+diketo forms), 2.26 (1.6H, t, J = 7.1 Hz, H-5 keto-enol form), 2.0 
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(0.2H, m, CH-Cy diketo form), 1.55-1.51 (4.8H, m, H-3 and H-4 keto-enol+diketo forms and 
CH-Cy keto-enol form), 1.09 and 0.92 (2H each, each m, CH2CH2-Cy keto-enol+diketo forms); 
13C NMR (CDCl3) (only the signals of the major keto-enol tautomer 6a are given) δ (ppm) 199.0 
(C-8), 187.3 (C-6), 173.7 (CO2Me), 98.8 (C-7), 51.5 (CO2Me) 36.3 (C-5), 33.6 (C-2), 25.3 (C-3), 
24.3 (C-4), 18.5 (CH-Cy), 10.2 (CH2CH2-Cy); IR (NaCl) vmax/cm
-1 3008, 2945, 2863, 1735, 1609, 
1440, 1377, 932, 777. 
 
Preparation of methyl 5-(6-cyclopropyl-2-(phenylamino)pyrimidin-4-yl)pentanoate (8). A mixture of 
phenylguanidine nitrate salt (7, 289.1 mg, 1.459 mmol, 1.6 equiv.), Na2CO3 (76.3 mg, 0.72 mmol, 
0.8 equiv.) and keto-enol 6 (203.6 mg, 0.90 mmol) in MeOH (2.5 mL) contained in a sealed 
ampoule was heated with stirring at 80 ºC for 24 h. The reaction mixture was poured into water 
and extracted with EtOAc. The organic extracts were washed with brine, dried over anhydrous 
Na2SO4 and concentrated to give an oily residue that was purified by chromatography, using 
hexane-EtOAc 9:1, to afford the pyrimidine derivative 8 (231.3 mg, 79%) as an oil. 1H NMR 
(CDCl3) δ (ppm) 7.62 (2H, apparent dd, part AA’ of an AA’BB’C system, J = 7.5, 0.9 Hz, H-2/H-6 
Ph), 7.30 (2H, apparent t, part BB’ of an AA’BB’C system, J = 7.5 Hz, H-3/H-5 Ph), 7.01 (1H, br s, 
NH), 6.97 (1H, apparent tt, part C of an AA’BB’C system, J = 7.5, 0.9 Hz, H-4 Ph), 6.49 (1H, s, 
H-5 Pym), 3.67 (3H, s, CO2Me), 2.59 (2H, t, J = 7.2 Hz, H-5), 2.36 (2H, t, J = 7.2 Hz, H-2), 1.86 
(1H, m, CH-Cy), 1.72 (4H, m, H-3 and H-4), 1.15 and 0.98 (2H each, each m, CH2CH2-Cy); 
13C 
NMR (CDCl3) δ (ppm) 173.9 (CO2Me), 172.5 (C-4 Pym), 169.8 (C-2 Pym), 159.8 (C-6 Pym), 
140.1 (C-1 Ph), 128.7 (C-3/C-5 Ph), 121.6 (C-4 Ph), 118.4 (C-2/C-6 Ph), 109.5 (C-5 Pym), 51.5 
(CO2Me), 37.1 (C-5), 33.8 (C-2), 27.9 (C-4), 24.5 (C-3), 16.8 (CH-Cy), 10.3 (CH2CH2-Cy); IR 
(NaCl) vmax/cm
-1 3356, 3002, 2939, 2856, 1730, 1584, 1443, 1249, 1026, 754; MS (EI) m/z (%) 
325 (M+, 17), 324 (4), 295 (2), 294 (8), 266 (4), 252 (13), 226 (16), 225 (100), 224 (11), 178 (3); 
HRMS m/z calcd. for C19H23N3O2 325.17903, found 325.17933. 
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Preparation of 5-(6-cyclopropyl-2-(phenylamino)pyrimidin-4-yl)pentanoic acid (Hapten CDb). A 
solution of methyl ester 8 (159 mg, 0.488 mmol) in MeOH (5.3 mL) and aqueous 2 M NaOH (0.98 
mL, 1.96 mmol, 4 equiv.) was stirred at 60 ºC for 1.5 h. The solvent was evaporated under 
reduced pressure, the resulting residue was dissolved in the minimum amount of formic acid and 
the solution again concentrated to dryness in vacuum. The white solid obtained was purified by 
chromatography, using CHCl3-EtOAc 9:1 as eluent, to give pure hapten CDb (129.3 mg, 85%) as 
a white solid. Mp 158-160 ºC (crystallized from benzene); 1H NMR (DMSO-d6) δ (ppm) 12.02 (1H, 
s, COOH), 9.32 (1H, s, NH), 7.74 (2H, apparent dd, part AA’ of an AA’BB’C system, J = 7.7, 0.9 
Hz, H-2/H-6 Ph), 7.23 (2H, apparent t, part BB’ of an AA’BB’C system, J = 7.7 Hz, H-3/H-5 Ph), 
6.88 (1H, apparent tt, part C of an AA’BB’C system, J = 7.3, 0.9 Hz, H-4 Ph), 6.67 (1H, s, H-5 
Pym), 2.54 (2H, t, J = 7.3 Hz, H-5), 2.25 (2H, t, J = 7.2 Hz, H-2), 1.95 (1H, m, CH-Cy), 1.67 (2H, 
m, H-4), 1.54 (2H, m, H-3), 1.03-0.97 (4H, m, CH2CH2-Cy); 
13C NMR (DMSO-d6) δ (ppm) 174.3 
(CO2H), 171.6 (C-4 Pym), 169.7 (C-2 Pym), 159.8 (C-6 Pym), 140.9 (C-1 Ph), 128.3 (C-3/C-5 
Ph), 120.7 (C-4 Ph), 118.3 (C-2/C-6 Ph), 108.8 (C-5 Pym), 36.4 (C-5), 33.4 (C-2), 27.5 (C-4), 
24.1 (C-3), 16.4 (CH-Cy), 9.9 (CH2CH2-Cy); IR (KBr) vmax/cm
-1 3290, 3138, 2936, 2360, 1684, 
1590, 1558, 1499, 1386, 1250, 970, 756, 689; MS (EI) m/z (%) 311 (M+, 24), 310(4), 309 (2), 266 
(4), 265 (6), 264 (14), 250 (4), 238 (11), 226 (14), 224 (16), 225 (100), 210 (4.5); HRMS m/z 
calcd. for C18H21N3O2  311.16338, found 311.16254. 
b) Synthesis of Hapten CDm  
 
Preparation of methyl 6-(3-guanidinophenyl)hexanoate (11). A mixture of methyl 
6-(3-aminophenyl)hexanoate (10, 188 mg, 0.850 mmol), 50% aqueous cyanamide solution (132 
µL, 1.70 minmmol, 2 equiv.) and concentrated HNO3 (70% w/v, 84 µL, 1.13 mmol, 1.3 equiv.) in 
EtOH (1.6 mL) was placed in a dark glass ampoule under nitrogen. The ampoule was sealed 
under vacuum and then heated with stirring at 78 ºC overnight. The content of the ampoule was 
transferred into a flask with the aid of EtOH, concentrated to dryness under vacuum and the 
residue purified by chromatography, using CHCl3-MeOH 9:1 as eluent, to give the aryl guanidine 
11 (242 mg, 87%). 1H NMR (300 MHz, CDCl3) δ (ppm) 9.62 (1H, s, NH-C(NH)-NH2), 7.92 (2H, br 
7 
 
s, NH-C(NH)-NH2), 6.60 (1H, br s, NH-C(NH)-NH2), 7.33 (1H, dd, J = 8.0, 8.0 Hz, H-5 Ph), 7.14 
(1H, d, J = 8.0 Hz, H-6 Ph), 7.07 (2H, m, H-2 and H-4 Ph), 3.64 (3H, s, CO2Me), 2.62 (2H, t, J = 
7.6 Hz, H-6), 2.30 (2H, t, J = 7.4 Hz, H-2), 1.64 (4H, m, H-3 and H-5), 1.35 (2H, m, H-4); 13C NMR 
(75 MHz, CDCl3) δ (ppm) 174.3 (CO2Me), 156.4 (NH-C(NH)-NH2), 145.1 (C-3 Ph), 134.0 (C-1 
Ph), 130.0 (C-5 Ph), 128.0 (C-4 Ph), 125.2 (C-6 Ph), 122.5 (C-2 Ph), 51.5 (CO2Me), 35.3 (C-6), 
33.8 (C-2), 30.6 (C-3), 28.5 (C-5), 24.5 (C-4); IR (NaCl) vmax/cm
-1 3338, 3200, 2940, 1724, 1674, 
1600, 1352, 1267, 736; MS (EI) m/z (%) 263 (M+, 100), 262 (13), 246 (4), 233 (3), 232 (18), 221 
(17), 190 (5), 170 (12), 148 (8), 132 (38); HRMS m/z calcd. for C14H21N3O2 263.16338, found 
263.16271. 
 
Preparation of methyl 6-(3-((4-cyclopropyl-6-methylpyrimidin-2-yl)amino)phenyl)hexanoate (12). A 
mixture of aryl guanidine 11 (143.1 mg, 0.438 mmol), 1-cyclopropylbutane-1,3-dione (9, 110.5 
mg, 0.876 mmol, 3 equiv.), Na2CO3 (23.2 mg, 0.219 mmol, 0.5 equiv.) and MeOH (1 mL) 
contained in a sealed glass ampoule was heated with stirring at 78 ºC for 48 h. The ampoule was 
opened and the solvent was removed under vacuum, giving a residue that was chromatographed 
on silica gel, using CHCl3 as eluent, to give the pyrimidine derivative 12 (96.5 mg, 62%) as an oil. 
1H NMR (300 MHz, CDCl3) δ (ppm) 7.50 (1H, dd, J = 1.6, 1.6 Hz, H-2 Ph), 7.39 (1H, ddd, J = 7.7, 
1.8, 1.6 Hz, H-4 Ph), 7.19 (1H, dd, J = 7.7, 7.7 Hz, H-5 Ph), 6.96 (1H, br s, H-NH), 6.80 (1H, ddd, 
J = 7.7, 1.6, 1.6 Hz, H-6 Ph), 6.51 (1H, s, H-5 Pym), 3.66 (3H, s, CO2Me), 2.60 (2H, t, J = 7.5 Hz, 
H-6), 2.34 (3H, s, Me), 2.31 (2H, t, J = 7.7 Hz, H-2), 1.85 (1H, m, CH-Cy), 1.67 (4H, m, H-3 and 
H-5), 1.39 (2H, m, H-4), 1.15 and 0.99 (2H each, each m, CH2CH2-Cy); 
13C NMR (75 MHz, 
CDCl3) δ (ppm) 174.2 (CO2Me), 172.4 (C-2 Pym), 166.6 (C-6 Pym), 159.8 (C-4 Pym), 143.1 (C-3 
Ph), 140.1 (C-1 Ph), 128.6 (C-5 Ph), 121.9 (C-4 Ph), 118.6 (C-6 Ph), 116.0 (C-2 Ph), 110.0 (C-5 
Pym), 51.4 (CO2Me), 35.9 (C-6), 34.0 (C-2), 31.0 (C-3), 28.7 (C-5), 24.8 (C-4), 23.8 (Me), 16.8 
(CH-Cy), 10.3 (CH2CH2-Cy); IR (NaCl) vmax/cm
-1 3356, 3009, 2932, 2850, 1736, 1588, 1541, 
1445, 1171, 789, 695; MS (EI) m/z (%) 353 (M+, 97), 352 (28), 323 (49), 322 (15), 294 (12), 280 
(17), 266 (11), 252 (51), 250 (87), 240 (17), 239 (100), 238 (23), 221 (20); HRMS m/z calcd. for 
C21H27N3O2 353.21033, found 353.21022. 
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Preparation of 6-(3-((4-cyclopropyl-6-methylpyrimidin-2-yl)amino)phenyl)hexanoic acid (Hapten 
CDm). A solution of methyl ester 12 (82.3 mg, 0.233 mmol) in a mixture of MeOH (2 mL) and 2M 
aqueous NaOH (0.47 mL, 0.932 mmol, 4 equiv.) was heated at reflux with stirring for 2 h. After 
removal of the solvent at reduced pressure, the solid residue obtained was dissolved in the 
minimum amount of formic acid and the resulting solution was stirred while treated dropwise with 
water until the apparition of a white precipitate. The mixture was cooled in the refrigerator for a 
few hours and filtered. The crystals were washed with cool water and dried overnight in the 
vacuum desiccator yielding hapten CDm (57.7 mg, 73%), practically pure by NMR analysis. Mp 
170-173 ºC (crystallized from DMSO-H2O); 
1H NMR (300 MHz, DMSO-d6) δ (ppm) 
13C NMR (75 
MHz, DMSO-d6) δ (ppm) 174.4 (CO2H), 171.4 (C-2 Pym), 166.2 (C-6 Pym), 159.8 (C-4 Pym), 
142.1 (C-3 Ph), 140.8 (C-1 Ph), 128.1 (C-5 Ph), 120.9 (C-4 Ph), 118.2 (C-6 Ph), 115.8 (C-2 Ph), 
109.4 (C-5 Pym), 35.3 (C-6), 33.5 (C-2), 30.5 (C-5), 28.2 (C-4), 24.3 (C-3), 23.3 (Me), 16.2 
(CH-Cy), 9.8 (CH2CH2-Cy); IR (KBr) vmax/cm
-1 3292, 3213, 3101, 3014, 2932, 2853, 1700, 1633, 
1604, 1558, 1487, 1452, 1404, 1264, 960, 784; HRMS (TOF MS ES+) m/z calcd. for 
C20H25N3NaO2 [M+Na]
+ 362.18445, found 362.18380. 
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Synthesis of Moiety Heterologous Haptens 
Heterologous haptens Clm and Clp were prepared by construction of the complete framework as 
detailed in Schemes S1 and S2. Their synthesis is based on the preliminary preparation of a 
conveniently functionalized phenylaminopyrimidine moiety followed by incorporation of the C6 
hydrocarbon chain that constitutes the spacer arm at the required position of the phenyl ring by a 
strategy based on the Sonogashira cross-coupling reaction. A detailed description of each 
synthetic step as well as the complete spectroscopic characterization data of the heterologous 
haptens and of all the intermediates of their synthesis are reported below. 
a) Synthesis of Hapten Clm 
 
Scheme S1. Synthetic pathway to prepare hapten Clm 
Preparation of N-(4-chloro-6-methylpyrimidin-2-yl)-N-(3-iodophenyl)formamide (15). A solution of 
aryl iodide 14 (244 mg, 0.988 mmol) in anhydrous THF (2.2 mL) was dropwise added to a stirred 
suspension of NaH (60% dispersion in mineral oil, 37 mg, 0.93 mmol, 1.1 equiv., prewashed with 
dry pentane) in THF (2.2 mL) under nitrogen. After the evolution of hydrogen ceased, about 30 
min, a solution of pyrimidine 13 (170 mg, 0.823 mmol) in anhydrous THF (3 mL) was added and 
the resulting mixture was stirred overnight, then poured into water and extracted with EtOAc. The 
combined organic layers were washed with brine and then dried over anhydrous Na2SO4. The 
residue left after evaporation of the solvent was chromatographed over silica gel, using hexane-
EtOAc from 9:1 to 8:2 as eluent, to afford compound 15 (181 mg, 59%) as a solid. Mp 178.5-
179.5 ºC (crystallized from cold hexane-Et2O). 
1H NMR (300 MHz, CDCl3) δ (ppm) 9.91 (1H, s, 
CHO), 7.75 (1H, dt, J = 7.0, 1.8 Hz, H-4 Ph), 7.55 (1H, m, H-2 Ph), 7.25-7.16 (2H, m, H-5 and H-
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6 Ph), 6.98 (1H, br s, H-Pym), 2.42 (3H, br s, Me-Pym); 13C NMR (75 MHz, CDCl3) δ (ppm) 170.4 
(C-6 Pym), 162.7 (CHO), 161.6 (C-2 Pym), 159.0 (C-4 Pym), 137.6 and 137.5 (C-4 and C-5 Ph), 
136.8 (C-1 Ph), 130.6 (C-2 Ph), 128.2 (C-6 Ph), 116.7 (C-5 Pym), 93.8 (C-3 Ph), 24.0 (Me-Pym); 
IR (KBr) vmax/cm
-1 3442, 3085, 1686, 1573, 1542, 1362, 1279, 1120, 754; HRMS (TOF MS ES+) 
m/z calcd. for C12H10ClIN3O2 [M+H]
+ 373.9557, found 373.9566. 
Preparation of tert-butyl 6-(3-(N-(4-chloro-6-methylpyrimidin-2-yl)formamido)phenyl)hex-5-ynoate 
(17). A mixture of CuI (0.7 mg, 0.0037 mmol), (Ph3P)2PdCl2 (7.8 mg, 0,011 mmol), aryl iodide 15 
(137 mg, 0.37 mmol) and tert-butyl hex-5-ynoate (16, 92.9 mg, 0.55 mmol) in anhydrous DMF 
(1.3 mL) was purged by three cycles of vacuum and nitrogen. Then, anhydrous Et3N (1.3 mL) 
was added and the resulting brownish solution obtained was stirred at room temperature for 4 
hours, then poured into water and extracted with EtOAc. The combined organic layers were 
washed with an aqueous solution of LiCl and brine, dried over anhydrous Na2SO4 and 
concentrated to dryness. Chromatography of the crude product, using hexane-EtOAc from 9:1 to 
8:2 as eluent, afforded aryl-alkyne 17 (111 mg, 73%). as an oil. 1H NMR (300 MHz, CDCl3) δ 
(ppm) 9.93 (1H, s, CHO), 7.44 (1H, dt, J = 7.5, 1.8 Hz, H-4 Ph), 7.39 (1H, ddd, J = 7.5, 7.5, 0.7 
Hz, H-5 Ph), 7.23 (1H, br t, J = 1.8 Hz, H-2 Ph), 7.11 (1H, dt, J = 7.5, 1.8 Hz, H-6 Ph), 6.96 (1H, 
br s, H-Pym), 2.45 (2H, J = 7.3 Hz, H-4), 2.41 (3H, br s, Me-Pym), 2.39 (2H, t, J = 7.5 Hz, H-2), 
1.87 (2H, quint, J = 7.5 Hz, H-3), 1.45 (9H, s, CMe3); 
13C NMR (75 MHz, CDCl3) δ (ppm) 172.5 
(CO2), 170.3 (C-6 Pym), 162.8 (CHO), 161.5 (C-2 Pym), 159.2 (C-4 Pym), 135.7 (C-3 Ph), 131.8 
(C-4 Ph), 131.6 (C-5 Ph), 129.1 (C-6 Ph), 128.1 (C-2 Ph), 125.2 (C-1 Ph), 116.5 (C-5 Pym), 90.2 
(C-5), 80.5 (C-6), 80.3 (CMe3), 34.4 (C-2), 28.1 (CMe3), 24.0 (Me-Pym), 23.9 (C-3), 18.8 (C-4); IR 
(KBr) vmax/cm
-1 2977, 2361, 1707, 1570, 1546, 1369, 1232, 1150, 1110; HRMS (TOF MS ES+) 
m/z calcd. for C22H24ClN3NaO2 [M+Na]
+ 436.1404, found 436.1411. 
Preparation of tert-butyl 6-(3-((4-chloro-6-methylpyrimidin-2-yl)amino)phenyl)hexanoate (18). A 
mixture of aryl-alkyne 17 (107 mg, 0.26 mmol) and PtO2 (10 mg) in EtOH (3.8 mL) was stirred 
under an atmosphere of hydrogen at 45-50 psi during 16 hours. The reaction mixture was filtered 
through a short silica-gel column using EtOAc to wash the column and the residue left after 
evaporation of the solvent was chromatographed on silica gel, using hexane-EtOAc from 9:1 to 
8:2 as eluent, to give compound 18 (81.1 mg, 75%) as an oil, followed by the corresponding 
N-formylated derivative 19 (7.6 mg, 7%) as a semisolid. Data for compound 18: 1H NMR (300 
MHz, CDCl3) δ (ppm) 7.49 (1H, br dd, J = 7.8, 1.2 Hz, H-4 Ph), 7.36 (1H, br t, J = 1.8 Hz, H-2 Ph), 
7.24 (1H, dd, J = 7.8, 7.8 Hz, H-5 Ph), 7.12 (1H, br s, NH), 6.87 (1H, br d, J = 7.8 Hz, H-6 Ph), 
6.63 (1H, s, H-Pym), 2.61 (2H, J = 7.5 Hz, H-6), 2.39 (3H, s, Me-Pym), 2.21 (2H, t, J = 7.5 Hz, 
H-2), 1.65 (4H, m, H-3 and H-5), 1.43 (9H, s, CMe3), 1.38 (2H, m, H-4); 
13C NMR (75 MHz, 
CDCl3) δ (ppm) 173.2 (CO2), 169.7 (C-6 Pym), 161.0 and 159.5 (C-2 and C-4 Pym), 143.4 (C-3 
Ph), 138.7 (C-1 Ph), 128.8 (C-5 Ph), 123.2 (C-6 Ph), 119.3 (C-4 Ph), 116.8 (C-2 Ph), 111.2 (C-5 
Pym), 79.9 (CMe3), 35.7 and 35.5 (C-6 and C-2), 30.9 (C-3), 28.6 (C-5), 28.1 (CMe3), 24.9 (C-4), 
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23.9 (Me-Pym); IR (KBr) vmax/cm
-1 3434, 2933, 1729, 1689, 1576, 1544, 1366, 1280, 1155, 771; 
HRMS (TOF MS ES+) m/z calcd. for C21H29ClN3O2 [M+H]
+ 390.1948, found 390.1951. 
Preparation of 6-(3-((4-chloro-6-methylpyrimidin-2-yl)amino)phenyl)hexanoic acid (Hapten Clm). 
A solution of tert-butyl ester 18 (29 mg, 0.074 mmol) in formic acid (1 mL) was stirred at rt for 6 
hours and then the excess of formic acid was removed using a rotary evaporator. The residue 
was dissolved in benzene and concentrated again to obtain hapten Clm (24.5 mg, 98.7%) as a 
solid. Mp 165.4-165.8 ºC (crystallized from MeOH); 1H NMR (300 MHz, THF-d8) δ (ppm) 8.95 
(1H, br s, NH), 7.64 (1H, br d, J = 7.8 Hz, H-4 Ph), 7.52 (1H, br t, J = 1.8 Hz, H-2 Ph), 7.15 (1H, 
dd, J = 7.8, 7.8 Hz, H-5 Ph), 6.80 (1H, br d, J = 7.8 Hz, H-6 Ph), 6.66 (1H, s, H-Pym), 2.60 (2H, J 
= 7.5 Hz, H-6), 2.34 (3H, s, Me-Pym), 2.22 (2H, t, J = 7.5 Hz, H-2), 1.64 (4H, m, H-3 and H-5), 
1.39 (2H, m, H-4); 13C NMR (75 MHz, THF-d8) δ (ppm) 174.6 (CO2H), 170.1 (C-6 Pym), 161.5 
and 161.1 (C-2 and C-4 Pym), 143.8 (C-3 Ph), 141.1 (C-1 Ph), 129.2 (C-5 Ph), 123.1 (C-6 Ph), 
120.1 (C-4 Ph), 117.5 (C-2 Ph), 111.0 (C-5 Pym), 36.8 (C-6), 34.3 (C-2), 32.1 (C-5), 29.8 (C-4), 
25.8 (C-3), 23.9 (Me-Pym); IR (KBr) vmax/cm
-1 3443, 3279, 3109, 2918, 2847, 1701, 1629, 1552, 
1491, 1293, 897, 777; HRMS (TOF MS ES+) m/z calcd. for C17H21ClN3O2 [M+H]
+ 334.1322, found 
334.1327. 
b) Synthesis of Hapten Clp 
 
Scheme S2. Synthetic pathway to prepare hapten Clp 
Preparation of N-(4-chloro-6-methylpyrimidin-2-yl)-N-(4-iodophenyl)formamide (21). Compound 
21 was synthesized by the same procedure as that used for 15. Starting from NaH (60% in 
mineral oil, 42.7 mg, 1.07 mmol, 1.1 equiv.), aryl iodide 20 (287 mg, 1.16 mmol) and 13 (200 mg, 
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0.97 mmol), compound 21 was obtained as a solid (242 mg, 67%). Mp 178.0-178.8 ºC 
(crystallized from cold hexane-Et2O). 
1H NMR (300 MHz, CDCl3) δ (ppm) 9.93 (1H, CHO), 7.80 
(2H, apparent dt, part AA’ of an AA’BB’ system, J = 8.7, 2.7 Hz, H-3/H-5 Ph), 6.97 (2H, apparent 
dt, part BB’ of an AA’BB’ system, J = 8.7, 2.7 Hz, H-2/H-6 Ph), 6.97 (1H, s, H-5 Pym), 2.42 (3H, s, 
Me-Pym); 13C NMR (75 MHz, CDCl3) δ (ppm) 170.4 (C-6 Pym), 162.7 (CHO), 161.5 (C-2 Pym), 
159.0 (C-4 Pym), 138.5 (C-2/C-6 Ph), 135.5 (C-1 Ph), 130.6 (C-3/C-5 Ph), 116.6 (C-5 Pym), 94.0 
(C-4 Ph), 24.0 (Me-Pym); IR (KBr) vmax/cm
-1 3426, 3076, 1693, 1572, 1543, 1365, 2191, 1120, 
1012, 763; HRMS (TOF MS ES+) m/z calcd. for C12H9ClIN3NaO2 [M+Na]
+ 395.9377, found 
395.9388. 
Preparation of tert-butyl 6-(4-(N-(4-chloro-6-methylpyrimidin-2-yl)formamido)phenyl)hex-5-ynoate 
(22). This compound was prepared following the same procedure as described for compound 17. 
Starting from CuI (0.8 mg, 0.0042 mmol), (Ph3P)2PdCl2 (8.8 mg, 0.012 mmol), aryl iodide 21 (160 
mg, 0.428 mmol), tert-butyl hex-5-ynoate (16, 108 mg, 0.640 mmol), DMF (1.5 mL) and Et3N (1.5 
mL), aryl alkyne 22 (139 mg, 78%) was obtained as a solid. Mp 89.2-90.4 ºC (crystallized from 
cold hexane-Et2O). 
1H NMR (300 MHz, CDCl3) δ (ppm) 9.93 (1H, CHO), 7.49 (2H, apparent dt, 
part AA’ of an AA’BB’ system, J = 8.7, 2.7 Hz, H-3/H-5 Ph), 7.12 (2H, apparent dt, part BB’ of an 
AA’BB’ system, J = 8.7, 2.7 Hz, H-2/H-6 Ph), 6.96 (1H, s, H-5 Pym), 2.48 (2H, J = 7.2 Hz, H-4), 
2.41 (2H, t, J = 7.5 Hz, H-2), 2.40 (3H, s, Me-Pym), 1.89 (2H, quint, J = 7.5 Hz, H-3), 1.46 (9H, s, 
CMe3); 
13C NMR (75 MHz, CDCl3) δ (ppm) 172.5 (CO2), 170.3 (C-6 Pym), 162.8 (CHO), 161.5 
(C-2 Pym), 159.2 (C-4 Pym), 135.0 (C-4 Ph), 132.5 (C-2/C-6 Ph), 128.5 (C-3/C-5 Ph), 124.0 (C-1 
Ph), 116.5 (C-5 Pym), 90.1 (C-5), 80.7 (C-6), 80.3 (CMe3), 34.4 (C-2), 28.1 (CMe3), 24.1 (C-3), 
23.9 (Me-Pym), 18.8 (C-4); IR (KBr) vmax/cm
-1 2979, 2932, 2360, 1710, 1570, 1548, 1369, 1159, 
1279, 1116, 775; HRMS (TOF MS ES+) m/z calcd. for C22H24ClN3NaO2 [M+Na]
+ 436.1404, found 
436.1407. 
Preparation of tert-butyl 6-(4-((4-chloro-6-methylpyrimidin-2-yl)amino)phenyl)hexanoate (23). The 
transformation of aryl alkyne 22 (105 mg, 0.253 mmol) into 23 (76 mg, 77%) was undertaken 
following the procedure described for the transformation of 17 into 18 using PtO2 (9 mg) and 
EtOH (3.7 mL). A small amount of the N-formylated derivative 24 (7 mg, 7%) was also obtained 
from the same reaction. Data for compound 23: Mp 70.7-71.8 ºC (crystallized from cold hexane-
Et2O). 
1H NMR (300 MHz, CDCl3) δ (ppm) 7.50 (2H, br d, J = 8.5 Hz, H-3/H-5 Ph), 7.13 (2H, br d, 
J = 8.5 Hz, H-2/H-6 Ph), 7.06 (1H, br s, NH), 6.61 (1H, s, H-5 Pym), 2.58 (2H, J = 7.5 Hz, H-6), 
2.39 (3H, s, Me-Pym), 2.20 (2H, t, J = 7.5 Hz, H-2), 1.61 (4H, m, H-3 and H-5), 1.43 (9H, s, 
CMe3), 1.35 (2H, m, H-4); 
13C NMR (75 MHz, CDCl3) δ (ppm) 173.2 (CO2), 169.7 (C-6 Pym), 
161.0 (C-2), 159.5 (C-4 Pym), 137.4 (C-1 Ph), 136.4 (C-4 Ph), 128.8 (C-2/C-6 Ph), 119.4 
(C-3/C-5 Ph), 111.1 (C-5 Pym), 80.0 (CMe3), 35.5 (C-6), 35.1 (C-2), 31.2 (C-3), 28.6 (C-5), 28.1 
(CMe3), 24.9 (C-4), 23.9 (Me-Pym); IR (KBr) vmax/cm
-1 3421, 3356, 2971, 2923, 1719, 1529, 1413, 
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13676, 1151, 1121, 796; HRMS (TOF MS ES+) m/z calcd. for C21H29ClN3O2 [M+H]
+ 390.1948, 
found 390.1950. 
Preparation of 6-(4-((4-chloro-6-methylpyrimidin-2-yl)amino)phenyl)hexanoic acid (Hapten Clp). 
Hydrolysis of the tert-butyl ester moiety of 23 (31.5 mg, 0.081 mg) to give hapten Clp (25.6 mg, 
95%) was realized as described above for the same transformation of 18 into hapten Clm. Data 
for hapten Clp: Mp 156-158 ºC (crystallized from MeOH). 1H NMR (300 MHz, THF-d8) δ (ppm) 
8.94 (1H, br s, NH), 7.62 (2H, br d, J = 8.4 Hz, H-3/H-5 Ph), 7.09 (2H, br d, J = 8.4 Hz, H-2/H-6 
Ph), 6.64 (1H, s, H-5 Pym), 2.57 (2H, J = 7.5 Hz, H-6), 2.33 (3H, s, Me-Pym), 2.22 (2H, t, J = 7.5 
Hz, H-2), 1.62 (4H, m, H-3 and H-5), 1.37 (2H, m, H-4); 13C NMR (75 MHz, THF-d8) δ (ppm) 
174.6 (CO2), 170.6 (C-6 Pym), 161.5 and 161.1 (C-2 and C-4 Pym), 138.8 (C-1 Ph), 137.2(C-4 
Ph), 129.2 (C-2/C-6 Ph), 120.1 (C-3/C-5 Ph), 110.9 (C-5 Pym), 36.1 (C-6), 34.3 (C-2), 32.4 (C-5), 
29.8 (C-4), 25.8(C-3), 23.9 (Me-Pym); IR (KBr) vmax/cm
-1 3431, 3290, 3118, 2922, 1701, 1613, 
1559, 1509, 1295, 900, 720; HRMS (TOF MS ES+) m/z calcd. for C17H21ClN3O2 [M+H]
+ 334.1322, 
found 334.1327. 
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Table S1 
Assay parameters obtained from the checkerboard characterization of cyprodinil antibodies using homologous and 
linker site-heterologous conjugates. 
Ab 
Assay 
hapten 
Direct cELISA  Indirect cELISA 
Ab 
dilution 
(×103) 
[HRP‒ 
hapten] 
(µg/L) Amax Slope 
IC50 
(µg/L)  
Ab 
dilution 
(×103) 
[OVA‒ 
hapten] 
(µg/L) Amax Slope 
IC50 
(µg/L) 
CDp#1 CDp 30 10 1.68 0.55 4.03  10 10 0.93 0.58 3.88 
 CDm 30 10 1.74 0.56 0.68  30 100 1.45 0.69 3.36 
 CDn 10 300 ---a    3 1000 ---   
 CDb 10 300 ---    10 1000 1.31 0.65 5.25 
CDp#2 CDp 30 3 0.92 0.64 1.76  10 10 1.10 0.64 3.30 
 CDm 30 3 1.03 0.72 0.38  100 100 1.12 0.64 1.96 
 CDn 10 300 ---    3 1000 ---   
 CDb 10 300 ---    10 100 1.09 0.95 0.17 
             
CDm#1 CDp 30 10 1.65 0.49 2.52  100 100 1.26 0.48 8.20 
 CDm 30 10 1.53 0.52 2.93  300 100 0.84 0.48 13.54 
 CDn 3 300 ---    3 1000 ---   
 CDb 30 100 0.73 0.58 0.90  100 1000 0.92 0.47 3.99 
CDm#2 CDp 3 10 1.52 0.67 2.82  100 100 1.24 0.56 6.80 
 CDm 30 3 0.81 0.62 2.01  300 100 0.96 0.52 5.75 
 CDn 10 300 ---    3 1000 ---   
 CDb 30 300 1.39 0.45 0.99  100 1000 0.90 0.51 9.91 
             
CDn#1 CDp 10 300 ---    3 1000 1.37 0.40 n.i.b 
 CDm 3 300 ---    3 1000 0.52 1.12 n.i. 
 CDn 30 10 1.30 0.59 58.92  30 10 1.32 0.39 n.i. 
 CDb 3 300 1.15 0.60 17.39  3 100 1.11 0.66 7.91 
CDn#2 CDp 30 300 ---    3 1000 1.25 0.63 n.i. 
 CDm 3 300 ---    3 1000 0.68 1.02 83.81 
 CDn 30 10 1.23 0.69 62.75  30 10 1.48 0.88 n.i. 
 CDb 3 300 ---    3 100 1.15 0.67 14.96 
             
CDb#1 CDp 3 10 1.41 0.78 1.04  10 100 1.16 0.73 2.07 
 CDm 10 10 1.36 0.94 0.65  10 100 1.04 0.62 2.59 
 CDn 10 3 0.84 0.80 1.13  3 1000 0.92 0.72 6.94 
 CDb 3 3 1.25 0.66 1.31  100 100 1.49 0.55 5.95 
CDb#2 CDp 10 300 ---    10 1000 0.84 0.58 11.99 
 CDm 3 300 ---    3 1000 1.05 0.54 50.35 
 CDn 30 300 ---    3 100 0.87 0.98 2.48 
 CDb 3 10 1.39 0.73 0.81  10 10 1.04 0.63 7.07 
a Absorbance lower than 0.5 units. b IC50 value was higher than 100 µg/L. 
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Table S2 
Assay parameters obtained for the checkerboard characterization of cyprodinil antibodies using moiety-
heterologous conjugates. 
Ab 
Assay 
hapten 
Direct cELISA  Indirect cELISA 
Ab 
dilution 
(×103) 
[HRP‒ 
hapten] 
(µg/L) Amax Slope 
IC50 
(µg/L)  
Ab 
dilution 
(×103) 
[OVA‒ 
hapten] 
(µg/L) Amax Slope 
IC50 
(µg/L) 
CDp#1 Clp 10 10 1.21 0.52 1.22  10 10 1.41 0.58 2.66 
CDp#2  30 100 1.36 0.88 2.01  30 10 1.18 0.59 0.68 
CDm#1  10 30 1.82 0.67 0.92  10 10 1.11 0.54 0.74 
CDm#2  10 10 0.84 0.73 1.98  10 10 1.51 0.65 0.59 
CDn#1  3 300 ---a    3 1000 ---   
CDn#2  3 300 ---    3 1000 ---   
CDb#1  3 300 0.71 0.72 2.66  3 100 1.70 0.93 12.32 
CDb#2  3 300 ---    10 1000 0.83 0.60 6.85 
             
CDp#1 Clm 10 30 0.95 0.55 0.29  30 100 1.25 0.62 0.99 
CDp#2  10 30 1.40 0.85 0.13  30 100 1.85 0.69 0.59 
CDm#1  10 10 1.03 0.75 1.80  100 100 1.60 0.50 15.07 
CDm#2  30 30 1.35 1.02 3.60  30 10 1.05 0.63 2.57 
CDn#1  3 300 ---    3 1000 1.31 0.86 10.54 
CDn#2  3 300 ---    3 1000 ---   
CDb#1  3 300 ---    10 100 1.08 0.31 0.88 
CDb#2  3 300 ---    10 1000 0.53 0.80 7.75 
a Absorbance lower than 0.5 units. 
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Fig. S1. Radar line plots of cross-reactivity values (%) for pyrimethanil 
(grey) and mepanipyrim (ochre) by homologous indirect cELISA 
obtained with each pair of antibodies generated from every immunizing 
hapten. 
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Fig. S2. Inhibition curves of the proposed direct and indirect cELISAs 
obtained with different dilutions of white (A), red (B), and sparkling (C) wine, 
and cider (D). 
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Copies of 1H NMR spectra of haptens 
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   1H NMR spectrum of hapten CDb (300 MHz, DMSO-d6) 
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1H NMR spectrum of hapten CDm (300 MHz, DMSO-d6) 
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1H NMR spectrum of hapten Clm (300 MHz, THF-d8) 
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 1H NMR spectrum of hapten Clp (300 MHz, THF-d8) 
 
